These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30210684)

  • 21. Long Non-coding RNAs LINC01679 as a Competitive Endogenous RNAs Inhibits the Development and Progression of Prostate Cancer via Regulating the miR-3150a-3p/SLC17A9 Axis.
    Mi YY; Sun CY; Zhang LF; Wang J; Shao HB; Qin F; Xia GW; Zhu LJ
    Front Cell Dev Biol; 2021; 9():737812. PubMed ID: 34900992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3.
    Yang Y; Nan Y; Du YH; Huang SC; Lu DD; Zhang JF; Li X; Chen Y; Zhang L; Yuan L
    World J Gastroenterol; 2023 Jul; 29(27):4317-4333. PubMed ID: 37545635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway.
    Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M
    Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177
    [No Abstract]   [Full Text] [Related]  

  • 24. miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer.
    Ge J; Mao L; Xu W; Fang W; Wang N; Ye D; Dong Z; Guan H; Guan C
    J Invest Surg; 2021 Sep; 34(9):984-992. PubMed ID: 32166986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
    Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X
    Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1.
    Hu S; Zhou Q; Lu Q; Guo X; Wang Y; Duan YX
    Kaohsiung J Med Sci; 2023 Dec; 39(12):1178-1189. PubMed ID: 37772770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-495-3p inhibits the cell proliferation, invasion and migration of osteosarcoma by targeting C1q/TNF-related protein 3.
    Zhao G; Zhang L; Qian D; Sun Y; Liu W
    Onco Targets Ther; 2019; 12():6133-6143. PubMed ID: 31447563
    [No Abstract]   [Full Text] [Related]  

  • 29. MicroRNA-148a-3p suppresses cell proliferation and migration of esophageal carcinoma by targeting CEP55.
    Lin Y; Chen Y; Shen R; Chen D; Lin Y
    Cell Mol Biol Lett; 2021 Dec; 26(1):54. PubMed ID: 34952571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circ_0136666 aggravates osteosarcoma development through mediating miR-1244/CEP55 axis.
    Gao X; Xu N; Miao K; Huang G; Huang Y
    J Orthop Surg Res; 2022 Sep; 17(1):421. PubMed ID: 36109749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
    Peng X; Yan B; Shen Y
    Breast Cancer; 2018 Nov; 25(6):742-752. PubMed ID: 29951881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11.
    Wang Y; Xu H; Si L; Li Q; Zhu X; Yu T; Gang X
    Prostate; 2018 May; 78(7):479-490. PubMed ID: 29542173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer.
    Wang Z; Zhang X; Liu Y; Shi X; Li L; Jia Y; Wu F; Cui H; Li L
    Histol Histopathol; 2023 Dec; 38(12):1403-1413. PubMed ID: 36825753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
    Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
    Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-1291 mediates cell proliferation and tumorigenesis by downregulating MED1 in prostate cancer.
    Cai Q; Zhao A; Ren L; Chen J; Liao K; Wang Z; Zhang W
    Oncol Lett; 2019 Mar; 17(3):3253-3260. PubMed ID: 30867757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
    Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-501-3p inhibits the proliferation of kidney cancer cells by targeting WTAP.
    He L; Chen S; Ying Y; Xie H; Li J; Ma X; Wang W; Shen H; Wang X; Zheng X; Xie L
    Cancer Med; 2021 Oct; 10(20):7222-7232. PubMed ID: 34595849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop.
    Luo P; Wang Q; Ye Y; Zhang J; Lu D; Cheng L; Zhou H; Xie M; Wang B
    J Exp Clin Cancer Res; 2019 Feb; 38(1):74. PubMed ID: 30755230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2.
    Song BF; Xu LZ; Jiang K; Cheng F
    Funct Integr Genomics; 2023 Mar; 23(2):80. PubMed ID: 36884182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.